Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Asthma Mortality and Long-Acting Beta<sub>2</sub>-Agonists in Five Major European Countries, 1994–2004 — Liliane Chatenoud (2009) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Asthma Mortality and Long-Acting Beta<sub>2</sub>-Agonists in Five Major European Countries, 1994–2004
Shared by
Carlo La Vecchia
Universita' degli Studi di MILANO
Asthma Mortality and Long-Acting Beta<sub>2</sub>-Agonists in Five Major European Countries, 1994–2004
Article
2009
en
Authors
+2 more
LC
Liliane Chatenoud
MM
Matteo Malvezzi
AP
Andrea Pitrelli
Abstract
1 min read
While the use of LABAs (with or without ICS) increased over the last decade, asthma mortality declined in major western European countries.
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2011
p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β<sub>2</sub>Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma
Nicolas Mercado
,
Yasuo To
,
Yoshiki Kobayashi
,
Ian M. Adcock
,
Peter J Barnes
,
Kazuhiro Ito
Article
2015
Laryngeal cancer mortality trends in <scp>E</scp>uropean countries
Liliane Chatenoud
,
Werner Garavello
,
Eleonora Pagan
,
Paola Bertuccio
,
Silvano Gallus
,
Carlo La Vecchia
,
Eva Negri
,
Cristina Bosetti
Article
2012
Do inhaled corticosteroid/long-acting beta<sub>2</sub>-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal
Peter J Barnes
,
Gabriele Nicolini
,
Andrea Bizzi
,
Monica Spinola
,
Dave Singh
Article
2002
Scientific rationale for inhaled combination therapy with long-acting β<sub>2</sub>-agonists and corticosteroids
Peter J Barnes
Article
1994
Comparison of cancer mortality trends in major European areas, 1960–89
Silvia Franceschi
,
Fabio Levi
,
Carlo La Vecchia
,
F Lucchini
,
Eva Negri
Discussion(0)
No comments yet. Be the first to comment.